Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.65 |
| ▸ | RECQL | P46063 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.65 |
| ▸ | SOST | Q9BQB4 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.64 |
| ▸ | APP | P05067 | 1/20 | 0.64 |
| ▸ | XDH | P47989 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dihydromorin SCHEMBL29929436 | 1.00 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| Dihydromorin SCHEMBL10174295 | 1.00 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| Dihydromorin SCHEMBL29929680 | 1.00 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| Dihydromorin SCHEMBL6819045 | 1.00 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| SCHEMBL15197248 | 0.89 | MAPT (0.60) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| SCHEMBL27796495 | 0.89 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| SCHEMBL3362576 | 0.89 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| SCHEMBL15530038 | 0.86 | SOST (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| SCHEMBL28841492 | 0.84 | MAPT (0.67) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| SCHEMBL27222267 | 0.84 | MAPT (0.67) | MAPTCYP3A4ALOX15RECQLMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20240016777-A1 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 2024-01-18 | — | — | US | claimed |
| EP-4243809-A2 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | Beth Israel Deaconess Medical Center, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| CN-112089638-B | Composition for inhibiting melanin synthesis | 香港大学 | 2023-05-12 | — | — | CN | claimed |
| CN-115902033-A | Method for quality detection of cudrania cochinchinensis and rapid detection and identification of metabolites of cudrania cochinchinensis | 金俊杰 | 2023-04-04 | — | — | CN | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| CN-113476438-B | Hypoglycemic composition containing dihydro morin and application thereof | 中国农业科学院郑州果树研究所 | 2022-09-09 | — | — | CN | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022104153-A2 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2022-05-19 | — | — | WO | claimed |
| CN-121652937-A | Rope-shaped basket-shaped bacteria and application thereof in morin synthesis | 山东省妇幼保健院 | 2026-03-13 | — | — | CN | disclosed |
| US-20250161394-A1 | Compositions Comprising Kavalactones | NATURAL EXTRACTION SYS LLC (US) | 2025-05-22 | — | — | US | disclosed |
| CN-114507645-B | Flavonoid reductase and application thereof | 安徽吐露港生物科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | disclosed |
| US-20240016777-A1 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 2024-01-18 | — | — | US | disclosed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | disclosed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | disclosed |
| WO-2022104153-A2 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2022-05-19 | — | — | WO | disclosed |
| CN-114507645-A | Novel flavone reductase and application thereof | 艾博锐克生物科技(山东)有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-114053340-A | A Chinese medicinal composition for treating rheumatism, and its preparation method | 吉林吉春制药股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | MAPT 3926/4885CYP3A4 3571/4885ALOX15 359/4885 |
| US-20240016777-A1 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | THPO, SERPINB1, SERPINC1 | MAPT 2717/4885CYP3A4 1420/4885ALOX15 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.